CDO

Edible® Names Industry Veteran Mark Mele as Chief Development Officer

Retrieved on: 
Tuesday, January 30, 2024

ATLANTA, Jan. 30, 2024 /PRNewswire/ -- Edible®, a modern e-commerce gifting brand uniquely supported by nearly 1,000 locally owned retail locations globally, today announced the appointment of Mark Mele as Chief Development Officer (CDO). With nearly four decades of experience in franchise development, most recently with Paris Baguette, Mele is poised to drive store growth for Edible's new Next-Gen store concept.

Key Points: 
  • ATLANTA, Jan. 30, 2024 /PRNewswire/ -- Edible ®, a modern e-commerce gifting brand uniquely supported by nearly 1,000 locally owned retail locations globally, today announced the appointment of Mark Mele as Chief Development Officer (CDO).
  • With nearly four decades of experience in franchise development, most recently with Paris Baguette, Mele is poised to drive store growth for Edible's new Next-Gen store concept.
  • His holistic approach to franchise management will lead the development of Edible's new and immersive in-person retail experience.
  • Before joining Edible, Mele was the Chief Development Officer for Paris Baguette, a global bakery café chain, where he managed franchise sales, real estate and construction and successfully rolled out a new café prototype systemwide.

Arvind Murali Joins Paradigm Technology as Chief Data Officer

Retrieved on: 
Friday, January 19, 2024

SCOTTSDALE, Ariz., Jan. 19, 2024 /PRNewswire-PRWeb/ -- Paradigm Technology is pleased to announce the appointment of Arvind Murali as its new Chief Data Officer (CDO). With a remarkable 25-year track record in digital and data transformation delivery, Arvind brings a wealth of experience to the leadership team.

Key Points: 
  • SCOTTSDALE, Ariz., Jan. 19, 2024 /PRNewswire-PRWeb/ -- Paradigm Technology is pleased to announce the appointment of Arvind Murali as its new Chief Data Officer (CDO).
  • Paradigm Technology is confident that Arvind Murali's extensive background and knowledge will significantly contribute to the Paradigm's growth and enhance its position as a leader in technology consulting.
  • As a seasoned professional, Arvind Murali has successfully built several Data Practices including Master Data Management (MDM) & Data Governance, Business Intelligence, and Data Science.
  • Paradigm Technology is confident that Arvind Murali's extensive background and knowledge will significantly contribute to the Paradigm's growth and enhance its position as a leader in technology consulting.

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Retrieved on: 
Tuesday, January 16, 2024

Leading biopharma executives Dieter Weinand (previously CEO at Bayer Pharmaceuticals) and Carsten Reinhardt (CDO at Immatics), join the DISCO Board of Directors as Chairman and Independent Director, respectively.

Key Points: 
  • Leading biopharma executives Dieter Weinand (previously CEO at Bayer Pharmaceuticals) and Carsten Reinhardt (CDO at Immatics), join the DISCO Board of Directors as Chairman and Independent Director, respectively.
  • COLOGNE, Germany and ZURICH, Jan. 16, 2024 /PRNewswire/ -- DISCO Pharmaceuticals ("DISCO"), a specialist biotech unlocking the surfaceome of cancer cells at scale to identify new targets and develop first in class drugs, emerges from stealth today.
  • The Company, operating out of Cologne, Germany and Schlieren, Switzerland, successfully raised seed financing of EUR 20 million and is backed by a world leading investor syndicate, including Sofinnova Partners, which led the round, Panakes Partners, M Ventures and AbbVie Ventures.
  • Roman Thomas, Founder and Chief Executive Officer, at DISCO Pharmaceuticals, said: "Today, we are launching DISCO Pharmaceuticals and its breakthrough technology after a decade of research by our exceptional team.

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Retrieved on: 
Tuesday, January 16, 2024

Leading biopharma executives Dieter Weinand (previously CEO at Bayer Pharmaceuticals) and Carsten Reinhardt (CDO at Immatics), join the DISCO Board of Directors as Chairman and Independent Director, respectively.

Key Points: 
  • Leading biopharma executives Dieter Weinand (previously CEO at Bayer Pharmaceuticals) and Carsten Reinhardt (CDO at Immatics), join the DISCO Board of Directors as Chairman and Independent Director, respectively.
  • COLOGNE, Germany and ZURICH, Jan. 16, 2024 /PRNewswire/ -- DISCO Pharmaceuticals ("DISCO"), a specialist biotech unlocking the surfaceome of cancer cells at scale to identify new targets and develop first in class drugs, emerges from stealth today.
  • The Company, operating out of Cologne, Germany and Schlieren, Switzerland, successfully raised seed financing of EUR 20 million and is backed by a world leading investor syndicate, including Sofinnova Partners, which led the round, Panakes Partners, M Ventures and AbbVie Ventures.
  • Roman Thomas, Founder and Chief Executive Officer, at DISCO Pharmaceuticals, said: "Today, we are launching DISCO Pharmaceuticals and its breakthrough technology after a decade of research by our exceptional team.

Layne's Chicken Fingers Welcomes Eric Reed to the Corporate Team as New Chief Development Officer

Retrieved on: 
Friday, January 12, 2024

FRISCO, Texas, Jan. 12, 2024 /PRNewswire-PRWeb/ -- Layne's Chicken Fingers, the Soon to be Famous™ chicken franchise with 13 restaurants open and another 113 sold, is following an incredible growth trajectory. Now, part-owner Eric Reed is joining the team as Chief Development Officer, bringing decades of real estate experience and a deep love for the brand, to support the system's ongoing growth.

Key Points: 
  • Now, part-owner Eric Reed is joining the team as Chief Development Officer, bringing decades of real estate experience and a deep love for the brand, to support the system's ongoing growth.
  • We were always looking for ways to make money during elementary school, and we've had our little entrepreneurial ventures," said Reed.
  • "As I support franchisees in their growth with Layne's, I'll be pulling from my previous development experience," explained Reed.
  • Reed will provide valuable support for franchisees during this development process, working with the team to make Layne's — and the Astro Chicken — well-known nationwide.

Grandview Analytics Announces 2023 Milestones and 10-Year Anniversary

Retrieved on: 
Wednesday, January 10, 2024

CHICAGO, Jan. 10, 2024 /PRNewswire-PRWeb/ -- Chicago-based Grandview Analytics, a leading technology consulting and data management software company for financial institutions, is pleased to announce strong momentum heading into 2024. Though it was a challenging year for the financial services industry, Grandview was able to grow its client base by 30% and made strategic investments in staffing and technology infrastructure to support continued growth in its consulting and managed data service businesses. Founded in 2014, the company is thrilled to celebrate these successes in conjunction with its 10-year anniversary.

Key Points: 
  • Founded in 2014, the company is thrilled to celebrate these successes in conjunction with its 10-year anniversary.
  • "We are proud to have worked with several new clients in 2023 across our consulting and software businesses," said Matt Biver, co-founder and CEO.
  • Rivvit and managed data service growth: As an emerging leader in investment data management technology, Grandview was proud to win new business for its outsourced managed data service and Rivvit data management and reporting platform in 2023.
  • Grandview won an engagement with an insurance company that chose Rivvit as its strategic data management and reporting solution.

Samsung Biologics presents 2024 business plans at J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 10, 2024

INCHEON, South Korea, Jan. 9, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business plans and strategy at the J.P. Morgan Healthcare Conference held in San Francisco, California.

Key Points: 
  • INCHEON, South Korea, Jan. 9, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business plans and strategy at the J.P. Morgan Healthcare Conference held in San Francisco, California.
  • "This year, we expect to face fiercer competition and challenges as we prepare for the next decade of growth," said Rim.
  • The company is also building an antibody-drug conjugate (ADC) facility at a separate site, with the aim to commence operations by 2024.
  • "We will continue to build on our strong foundation of trust and pursue our mission to deliver high-quality biomedicines to as many patients around the world."

Leaders across every industry cite democratizing data and AI as the number one challenge to achieving their generative AI goals, according to a new MIT Technology Review Insights research report

Retrieved on: 
Tuesday, January 9, 2024

CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ -- A new report by MIT Technology Review Insights explores the breakthroughs in data intelligence that will enable CIOs to reach their data and generative AI priorities across seven industries, namely retail and consumer packaged goods, healthcare and life sciences, manufacturing, financial services, telecommunications, media and entertainment, and the public sector.

Key Points: 
  • "Organizations investing in unified data and governance platforms to fuel their AI and empower their workforces are positioned to lap the competition in realizing AI-based results."
  • The findings are as follows:
    Real-time analytics and secure sharing are priorities in every industry to unleash the power of data truly.
  • Sixty-four percent of CIOs say the ability to securely share live data and AI assets across platforms is "very important."
  • Still, in every case, value creation will depend on access to data and AI across roles within the organization.

Leaders across every industry cite democratizing data and AI as the number one challenge to achieving their generative AI goals, according to a new MIT Technology Review Insights research report

Retrieved on: 
Tuesday, January 9, 2024

CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ -- A new report by MIT Technology Review Insights explores the breakthroughs in data intelligence that will enable CIOs to reach their data and generative AI priorities across seven industries, namely retail and consumer packaged goods, healthcare and life sciences, manufacturing, financial services, telecommunications, media and entertainment, and the public sector.

Key Points: 
  • "Organizations investing in unified data and governance platforms to fuel their AI and empower their workforces are positioned to lap the competition in realizing AI-based results."
  • The findings are as follows:
    Real-time analytics and secure sharing are priorities in every industry to unleash the power of data truly.
  • Sixty-four percent of CIOs say the ability to securely share live data and AI assets across platforms is "very important."
  • Still, in every case, value creation will depend on access to data and AI across roles within the organization.

BoeFly's Latest Confidence Index Reveals Concerns About Rising Interest Rates Among Franchisors

Retrieved on: 
Monday, January 8, 2024

This most recent index was used to assess whether significant shifts in franchisor executive confidence occurred throughout 2023, building upon data from the two previous quarterly surveys.

Key Points: 
  • This most recent index was used to assess whether significant shifts in franchisor executive confidence occurred throughout 2023, building upon data from the two previous quarterly surveys.
  • According to the latest findings, franchisors are growing increasingly concerned about the rising interest rates and its impact on their domestic growth goals.
  • A major contributing factor to this uncertainty is the apprehension surrounding rising interest rates, with 86.7 percent of respondents indicating that current rates are negatively impacting their growth plans.
  • For a full report on the Franchise Growth Confidence Index survey findings, visit https://boefly.com/blog/boefly-franchise-growth-confidence-index-3/ .